BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ProImmune Limited 

The Magdalen Centre
Oxford Science Park
Oxford    OX4 4GA  United Kingdom
Phone: 44-0-870-042-7279 Fax: 44-0-870-712-0588


SEARCH JOBS




Industry
Biotechnology

Segment
Life Sciences





 Company News
ProImmune Limited Introduces ProStorm™ In-Vitro Assay Service 9/18/2012 8:49:42 AM    More...
ProImmune Limited Announces Launch of Special Assay Service 3/29/2012 6:57:57 AM    More...
ProImmune Limited Publishes White Paper 'Managing Immunogenicity Risk Through Assay-based Rational Drug Design and Selection' 11/23/2011 9:34:38 AM    More...
ProImmune Limited Introduces ProPresent Assay for Measurement of Antigen Processing and Presentation 9/8/2011 10:52:29 AM    More...
ProImmune Limited Launches ProArray Ultra: A New Protein and Peptide Microarray Platform with True Analytical Grade Performance 6/15/2011 7:08:05 AM    More...
ProImmune Limited Services for Measuring Cell-Mediated Immune Responses Are Now Available In Formal Compliance with GLP and GCP 10/21/2010 1:01:07 PM    More...
ProImmune Limited Launches Novel Class-Leading CFSE T Cell Proliferation Assays for Assessing Drug Immunogenicity Risk 12/14/2009 8:30:51 AM    More...
ProImmune Limited Accelerates Development of Therapeutics with REVEAL(TM) B Cell Epitope Discovery System 3/9/2009 9:56:29 AM    More...
ProImmune Limited Launches REVEAL(TM) Immunogenicity System Services for Development and Testing of Biologics with Reduced Immunogenicity Combines, for the First Time, Cell-Free HLA-Peptide Binding Assays for More Than 50 Class II HLA Alleles With Highly Sensitive T Cell Proliferation Assays 11/18/2008 10:15:14 AM    More...
ProImmune Limited Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 9/24/2007 7:36:23 AM    More...
12